Amgen Inc (AMGN)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$347.50
Buy
$347.80
$-5.34 (-1.51%)
Prices updated at 03 Apr 2026, 00:50 EDT
| Prices minimum 15 mins delay
Prices in USD
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2025 | 67.25 |
| 2024 | 61.53 |
| 2023 | 70.02 |
| 2022 | 75.66 |
| 2021 | 75.16 |
| 2020 | 75.77 |
| 2019 | 81.35 |
| 2018 | 82.73 |
| 2017 | 82.19 |
| 2016 | 81.90 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2026 | 5.13 |
| 2025 | 4.93 |
| 2024 | 4.33 |
| 2023 | 5.77 |
| 2022 | 5.46 |
| 2021 | 5.05 |
| 2020 | 5.46 |
| 2019 | 6.39 |
| 2018 | 5.73 |
| 2017 | 5.58 |
| 2016 | 4.92 |
Price/Forward earnings (YTD)
15.85
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2025 | 8.45 |
| 2024 | 4.33 |
| 2023 | 8.28 |
| 2022 | 10.38 |
| 2021 | 9.50 |
| 2020 | 11.84 |
| 2019 | 12.44 |
| 2018 | 11.47 |
| 2017 | 2.51 |
| 2016 | 10.36 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2025 | 10.46 |
| 2024 | 15.63 |
| 2023 | 15.59 |
| 2022 | 17.79 |
| 2021 | 9.13 |
| 2020 | 6.69 |
| 2019 | 6.17 |
| 2018 | 5.31 |
| 2017 | 3.17 |
| 2016 | 2.60 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
